ææ°ã® Johnson & Johnson ã®æ ªåŒãã¥ãŒã¹ã決ç®ãã¢ããªã¹ãè©äŸ¡ãéèŠãªååã远跡ã§ããŸãã
10æ22æ¥ã®Johnson & Johnson (JNJ) å€åãã¯3.48%äžæïŒã©ã®ãããªã·ã°ãã«ã瀺ããŠããã®ãïŒ
10æ21æ¥ã®Moderna Inc (MRNA) å€åãã¯4.46%äžæïŒå€åãã®èåŸã«ããäºå®
10æ20æ¥ã®Eli Lilly and Co (LLY) å§å€ã¯5.01%äžæïŒæè³å®¶ãç¥ã£ãŠããã¹ãæ å ±
10æ20æ¥ã®Merck & Co Inc (MRK) å§å€ã¯3.79%äžæïŒäž»ãªæšé²èŠå ãæããã«ãããŸãã
10æ15æ¥ã®Novo Nordisk A/S (NVO) å€åãã¯3.38%äžæïŒå€åãã®èåŸã«ããäºå®
10æ15æ¥ã®Gilead Sciences Inc (GILD) å€åãã¯3.67%äžæïŒå®å šãªåæ
10æ15æ¥ã®AstraZeneca PLC (AZN) å€åãã¯3.55%äžæïŒã©ã®ãããªã·ã°ãã«ã瀺ããŠããã®ãïŒ
10æ15æ¥ã®Amgen Inc (AMGN) å€åãã¯3.01%äžæïŒæè³å®¶ãç¥ã£ãŠããã¹ãæ å ±
10æ15æ¥ã®Novartis AG (NVS) å€åãã¯3.00%äžæïŒã©ã®ãããªã·ã°ãã«ã瀺ããŠããã®ãïŒ
10æ15æ¥ã®Eli Lilly and Co (LLY) å§å€ã¯3.50%äžæïŒå€åãã®èåŸã«ããäºå®